SCHEMBL6741582

SCHEMBL6741582

c1ccc(-c2csc(-c3cccc(-c4ccccn4)n3)c2-c2ccccc2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 6/20 0.51
LMNA P02545 4/20 0.51
KDM4E B2RXH2 4/20 0.51
CCR1 P32246 3/20 0.51
CCR5 P51681 3/20 0.51
CCR8 P51685 3/20 0.51
TP53 P04637 3/20 0.51
ALOX15 P16050 2/20 0.51
HTT P42858 2/20 0.51
TDP1 Q9NUW8 2/20 0.51
L3MBTL1 Q9Y468 2/20 0.51
ALPL P05186 1/20 0.51
HSP90AA1 P07900 1/20 0.51
ALPI P09923 1/20 0.51
ALPG P10696 1/20 0.51
MAPK1 P28482 1/20 0.51
RAB9A P51151 7/20 0.46
NPC1 O15118 6/20 0.46
HPGD P15428 2/20 0.46
CASP3 P42574 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12914276 0.82 NPC1 (0.49) SMN1; SMN2LMNAKDM4ECCR1CCR5
SCHEMBL4949169 0.80 KDM4E (0.60) SMN1; SMN2LMNAKDM4ECCR1CCR5
SCHEMBL12912908 0.77 ALOX5AP (0.38) SMN1; SMN2LMNAKDM4EHTTMAPK1
SCHEMBL9952329 0.75 SMN1; SMN2 (0.67) SMN1; SMN2LMNAKDM4ECCR1CCR5
SCHEMBL24712477 0.74 KDM4E (0.78) SMN1; SMN2LMNAKDM4ECCR1CCR5
SCHEMBL29391170 0.74 KDM4E (0.78) SMN1; SMN2LMNAKDM4ECCR1CCR5
SCHEMBL1657392 0.74 KDM4E (0.78) SMN1; SMN2LMNAKDM4ECCR1CCR5
SCHEMBL12860033 0.74 RAB9A (0.48) SMN1; SMN2LMNAKDM4ETP53ALOX15
SCHEMBL12999304 0.73 KDM4E (0.64) SMN1; SMN2LMNAKDM4ECCR1CCR5
SCHEMBL12999271 0.73 KDM4E (0.64) SMN1; SMN2LMNAKDM4ECCR1CCR5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6696182-B2 HIGH PERFORMANCE DIPYRIDYL THIOPHENE OR DIPYRIDYL THIOPHENE DIOXIDE ELECTRON TRANSPORT MATERIALS WHICH WHEN EMPLOYED CAN GIVE LOW-VOLTAGE, HIGH EFFICIENCY ORGANIC ELECTROLUMINESCENT DEVICES CHISSO CORPORATION (JP) 2004-02-24 US disclosed
EP-1186605-B1 Organic electroluminescent device comprising dipyridylthiophene derivative CHISSO CORP (JP) 2003-04-16 EP disclosed
US-20020034658-A1 Organic electroluminescent device comprising dipyridylthiophene derivative CHISSO CORPORATION (JP) 2002-03-21 US disclosed
EP-1186605-A1 Organic electroluminescent device comprising dipyridylthiophene derivative CHISSO CORPORATION (JP) 2002-03-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020034658-A1 Organic electroluminescent device comprising dipyridylthiophene derivative LAGE3, MAL2, ELF3 SMN1; SMN2 3318/4885LMNA 2640/4885KDM4E 276/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.